NASDAQ:ACAD
ACADIA Pharmaceuticals Inc. Stock News
$16.71
+0.400 (+2.45%)
At Close: Apr 26, 2024
Madrigal Pharmaceuticals (MDGL) Gets a Buy Rating from Oppenheimer
11:31pm, Wednesday, 15'th Apr 2020
Oppenheimer analyst Jay Olson maintained a Buy rating on Madrigal Pharmaceuticals (MDGL) today and set a price target of $200.00. The company's shares
Madrigal Pharmaceuticals (MDGL) Gets a Buy Rating from Oppenheimer
11:31pm, Wednesday, 15'th Apr 2020
Oppenheimer analyst Jay Olson maintained a Buy rating on Madrigal Pharmaceuticals (MDGL – Research Report) today and set a price
ACADIA Pharmaceuticals to Announce First Quarter 2020 Financial Results on May 7, 2020
08:05pm, Wednesday, 15'th Apr 2020
ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report first quarter financial results on Thursday, May 7, 2020, after the clo
